Dr. Patrick S. Barousse, MD

Dr. Barousse practices at Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery.

Dr. Barousse's NPI, 1053759555, was assigned on June 6, 2013. Dr. Barousse graduated from LSU Health Shreveport School of Medicine in 2013. Dr. Barousse's Nevada license number on file is 18008.

Dr. Barousse's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery, at 8100 South Walker Bldg C, Oklahoma City, OK 73139 in Oklahoma County. The practice phone is (405) 602-6500.

Dr. Barousse's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery. Dr. Barousse is also affiliated with North Oaks Medical Center. The medical group on file is North Oaks Medical Center. Dmand AI also links Dr. Barousse to 4 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barousse practices, 4 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Barousse's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Barousse is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Barousse's licenses on file in 4 states: Nevada, Alabama, Louisiana and California.

Dmand AI lists amputation, arthritis, broken or dislocated ankle/ or foot, enthesopathy in foot or ankle, fluid in a joint, hip replacement, joint pain and leg, ankle or foot fracture among the conditions Dr. Barousse treats.

CMS data shows 200 Medicare services from Dr. Barousse across 6 procedure codes in 2024, for 146 Medicare patients. Medicare paid $11,524 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 146 Medicare patients who saw Dr. Barousse in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barousse's median patient age at 51, with 64% women.

In 2024, Dr. Barousse wrote 73 Medicare Part D claims for 34 patients. 100% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $221 in total drug cost. In 2023, CMS named 59 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Barousse for performance year 2024, reported as part of a group. Dr. Barousse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Barousse, published from 2016 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Ankle. Dr. Barousse's most frequent co-authors are Gregory Andrew Lundeen, MD, James R. Andrews, MD and Spenser Cassinelli, MD.

CMS Open Payments shows 165 general payments to Dr. Barousse from 19 drug and device companies from 2016 to 2025. Grants make up the largest share, 35% of the total. Arthrex, Inc. paid the most, $14,167.

Dr. Barousse graduated from LSU Health Shreveport School of Medicine in 2013.

Dr. Barousse is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.